Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Davis

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
American Journal of Clinical Pathology|January 13, 2000
Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirinM I Fiel, T D Schiano, M Guido, et al.
Journal of Viral Hepatitis|January 1, 1994
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy GroupG L Davis, K Lindsay, J Albrecht, et al.
Digestive Diseases and Sciences|January 24, 1998
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infectionD R Nelson, H L Lim, C G Marousis, et al.
Annals of Internal Medicine|January 1, 1986
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trialJ H Hoofnagle, G L Davis, S C Pappas, et al.
Digestive Diseases and Sciences|December 1, 1995
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis CR P González-Peralta, J W Fang, G L Davis, et al.
Journal of Hepatology|January 1, 1990
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy GroupG L Davis, L A Balart, E R Schiff, et al.
Journal of Hepatology|January 1, 1994
Optimization for the detection of hepatitis C virus antigens in the liverR P González-Peralta, J W Fang, G L Davis, et al.
Cancer Research|September 1, 1983
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cellsH F Dvorak, L Van DeWater, A M Bitzer, et al.
The New England Journal of Medicine|November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialG L Davis, L A Balart, E R Schiff, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
American Journal of Clinical Pathology|January 13, 2000
Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirinM I Fiel, T D Schiano, M Guido, et al.
Journal of Viral Hepatitis|January 1, 1994
Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy GroupG L Davis, K Lindsay, J Albrecht, et al.
Digestive Diseases and Sciences|January 24, 1998
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infectionD R Nelson, H L Lim, C G Marousis, et al.
Annals of Internal Medicine|January 1, 1986
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trialJ H Hoofnagle, G L Davis, S C Pappas, et al.
Digestive Diseases and Sciences|December 1, 1995
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis CR P González-Peralta, J W Fang, G L Davis, et al.
Journal of Hepatology|January 1, 1990
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy GroupG L Davis, L A Balart, E R Schiff, et al.
Journal of Hepatology|January 1, 1994
Optimization for the detection of hepatitis C virus antigens in the liverR P González-Peralta, J W Fang, G L Davis, et al.
Cancer Research|September 1, 1983
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cellsH F Dvorak, L Van DeWater, A M Bitzer, et al.
The New England Journal of Medicine|November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialG L Davis, L A Balart, E R Schiff, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Pageof 23